Systemic Sclerosis: Systemic Considerations and Work-Up

In a presentation on systemic sclerosis, Dr. Becca from the Harvard program discusses its complex nature as a multi-system autoimmune disease characterized by vascular changes, inflammation, and progressive fibrosis. The presentation covers diagnosis, phenotypes (limited vs. diffuse systemic sclerosis), skin and internal organ manifestations, and the importance of dermatologists in early screening for systemic involvement to improve patient outcomes. Key features of both phenotypes are highlighted, including skin involvement and potential progression to organ complications. Treatment options are explored, emphasizing a multidisciplinary approach, with medications such as Cellcept being preferred due to their safety profile and effectiveness in managing both skin and lung issues. The necessity of screening for extracutaneous manifestations like pulmonary and renal involvement, along with appropriate questions to ask patients for early detection, is also elaborated. Furthermore, the speaker mentions the significance of autoantibody testing for identifying patient subsets and tailoring treatments. Emphasis is placed on the importance of early diagnosis and intervention, as well as continuous monitoring for manifestations in various organ systems, urging collaboration among healthcare providers to optimize management and improve morbidity and mortality in systemic sclerosis patients.